免疫性血小板减少症、原发性血小板增多症、真性红细胞增多症。

1、Fu R, Dong H, Zhang D, Zhou H, Zhang X, Huang Y, et al. Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China. Ann Hematol. 2023;102(8):2097-107.（并列第一作者）。

2、Dong H, Li H, Fang L, Zhang A, Liu X, Xue F, et al. Increased reactive oxygen species lead to overactivation of platelets in essential thrombocythemia. Thromb Res. 2023;226:18-29. （并列通讯作者）。

3、Liu W, Xue F, Fu R, Ding B, Li M, Sun T, et al. Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors. J Thromb Haemost. 2023;21(6):1453-65.（并列第一作者）。